nach oben

Reactions Weekly

Erschienen in:

01.04.2015 | Case report

Oxaliplatin

Neuropathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

A 45-year-old man developed neuropathy while receiving oxaliplatin. The man had a history of metastatic duodenal adenocarcinoma. He experienced a recurrence, and he started receiving FOLFOX6 and bevacizumab treatment that included oxaliplatin [dosage and route not stated]. There was reduction of the tumour after 3 months. He developed oxaliplatin-related neuropathy [time to reaction onset not stated]. His chemotherapy was switched to capecitabine and bevacizumab. A complete response was achieved, and at last follow-up, he was disease-free. …

Nagaraj G, et al. Complete response and prolonged disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6. Journal of Gastrointestinal Oncology 5: E1-E6, No. 1, Feb 2014. Available from: URL: http://doi.org/10.3978/j.issn.2078-6891.2013.038 - USAPubMedCentralPubMed

Titel: Oxaliplatin
Neuropathy: case report
Publikationsdatum: 01.04.2015
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-015-0018-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Oxaliplatin

Neuropathy: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Metronidazole

Phenprocoumon

Dexamethasone/methylprednisolone

Afatinib/cetuximab

Ofloxacin

Olanzapine